LUMIZYME: payments to doctors
Payments that named LUMIZYME as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 1,138
- Transactions
- 2,243
- Average per transaction
- $642
The per-transaction average — $642 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,138 providers the average total is $1,265, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $1,311,423 | 91.1% |
| Sanofi-aventis U.S. LLC | $128,058 | 8.9% |